| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 164.70B | 172.10B | 180.34B | 199.32B | 148.93B | 112.48B |
| Gross Profit | 29.18B | 30.64B | 33.35B | 41.84B | 25.69B | 16.99B |
| EBITDA | 21.38B | 22.80B | 25.61B | 34.28B | 18.09B | 10.12B |
| Net Income | 9.98B | 11.58B | 13.56B | 19.70B | 8.47B | 3.76B |
Balance Sheet | ||||||
| Total Assets | 215.87B | 217.46B | 219.99B | 222.29B | 187.49B | 161.23B |
| Cash, Cash Equivalents and Short-Term Investments | 9.49B | 9.52B | 17.03B | 11.91B | 12.65B | 13.94B |
| Total Debt | 76.32B | 79.44B | 82.02B | 90.08B | 75.84B | 64.47B |
| Total Liabilities | 119.53B | 120.86B | 130.25B | 142.67B | 125.32B | 106.10B |
| Stockholders Equity | 96.16B | 96.41B | 89.49B | 79.61B | 62.16B | 55.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -250.00M | 18.76B | -9.48B | -16.73B | 4.53B |
| Operating Cash Flow | 0.00 | 11.04B | 26.82B | 3.65B | -697.00M | 11.18B |
| Investing Cash Flow | 0.00 | -11.39B | -7.92B | -13.04B | -15.66B | -6.78B |
| Financing Cash Flow | 0.00 | -7.39B | -14.32B | 8.53B | 15.05B | -8.00B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥763.23B | 9.48 | 10.78% | 4.68% | -1.97% | 47.63% | |
74 Outperform | ¥338.77B | 12.83 | ― | 3.26% | -7.77% | 58.84% | |
74 Outperform | ¥387.68B | 9.05 | 6.16% | 2.99% | -0.02% | -40.45% | |
71 Outperform | ¥70.23B | 8.43 | ― | 5.15% | -9.28% | -7.18% | |
70 Outperform | ¥100.13B | 10.61 | ― | 3.70% | -3.06% | 1.15% | |
67 Neutral | ¥184.64B | 11.58 | 5.06% | 1.80% | 4.10% | 152.90% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% |